Allspring Global Investments’s Vir Biotechnology VIR Stock Holding History

Allspring Global Investments’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$540K	Buy	+52,971	New	+$504K	﹤0.01%	1433
2024 Q1	–	Sell	-5,824	Closed	-$58.6K	–	2408
2023 Q4	$58.6K	Sell	5,824 -3,333	-36%	-$30.5K	﹤0.01%	1867
2023 Q3	$85.8K	Sell	9,157 -4,697	-34%	-$67K	﹤0.01%	2064
2023 Q2	$340K	Sell	13,854 -181,697	-93%	-$4.56M	﹤0.01%	1654
2023 Q1	$4.55M	Buy	195,551 +55,209	+39%	+$1.41M	0.01%	1024
2022 Q4	$3.55M	Buy	140,342 +128,106	+1,047%	+$3.14M	0.01%	1084
2022 Q3	$235K	Buy	12,236 +5,960	+95%	+$152K	﹤0.01%	1770
2022 Q2	$159K	Sell	6,276 -128,297	-95%	-$3M	﹤0.01%	1894
2022 Q1	$3.46M	Buy	134,573 +114,920	+585%	+$3.41M	﹤0.01%	1274
2021 Q4	$822K	Buy	+19,653	New	+$770K	﹤0.01%	2052

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allspring Global Investments's VIR Position: Q2 2026 in Review

Allspring Global Investments opened a new position in Vir Biotechnology (VIR) in Q2 2026: 52,971 shares worth $540K. The stake represents ﹤0.01% of the portfolio and ranks #1433 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in VIR as recently as Q4 2023.

Allspring Global Investments first reported a position in VIR in Q4 2021 and has held it in 10 quarters since. The position peaked at $4.55M in Q1 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Allspring Global Investments held 52,971 shares of Vir Biotechnology worth $540K as of Q2 2026.
Vir Biotechnology was a new Allspring Global Investments position in Q2 2026.
Vir Biotechnology made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1433 holding.
Allspring Global Investments first reported a position in Vir Biotechnology in Q4 2021 and has held it in 10 quarters since.
Allspring Global Investments's Vir Biotechnology position peaked at $4.55M in Q1 2023.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.